AbbVie And Biogen Make ICER's Unsupported Price Increase List Three Years Running

ICER's report on unsupported price increases highlighted seven drugs that cost the US health system $1.67bn due to price increases after rebates and other concessions.

prices for drugs — A ICER report highlights the top drugs with unsupported drug price increases • Source: Alamy

AbbVie Inc. and Biogen, Inc. have the dubious distinction of being the two pharmaceutical manufacturers that have made the Institute for Clinical and Economic Review's list of top drugs with unsupported price increases (UPIs) that had a substantial effect on US spending all three years the list has been published.

ICER issued its latest report on UPIs in the US on 16 November, highlighting seven drugs that lacked adequate new...